Device Liquid Embolics For Interventional Radiology

Instylla Delivery Kit

Payments companies reported to CMS as associated with Instylla Delivery Kit. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$306Kassociated payments (2023-2025)
74clinicians with associated payments
2companies reporting

By year

2023 $80K
2024 $130K
2025 $96K

Payments reported as associated with Instylla Delivery Kit, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular & Interventional Radiology $268K
Diagnostic Ultrasound $28K
Diagnostic Radiology $7,307
Internal Medicine $1,287
Gastroenterology (Internal Medicine) $1,125
Pediatric Radiology $176

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Instylla Delivery Kit

These are the largest totals companies reported as associated with Instylla Delivery Kit. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
David Tahour Long Beach, CA Vascular & Interventional Radiology $95,057.83
Kei Yamada Atlanta, GA Vascular & Interventional Radiology $37,179.98
Suvranu Ganguli Boston, MA Vascular & Interventional Radiology $32,395.78
Salomao Faintuch Boston, MA Diagnostic Ultrasound $27,954.98
Dimitry Rabkin Boston, MA Vascular & Interventional Radiology $24,017.48
Venkatesh Krishnasamy Birmingham, AL Vascular & Interventional Radiology $19,493.16
Eric Gandras Manhasset, NY Vascular & Interventional Radiology $16,215.14
Nadine Abi-Jaoudeh Orange, CA Vascular & Interventional Radiology $14,316.96
Michael Soulen Philadelphia, PA Vascular & Interventional Radiology $8,763.07
Edgar St Amour Little Rock, AR Vascular & Interventional Radiology $5,431.64

Prescribed Instylla Delivery Kit?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.